Development and validation of methods for the determination of miokamycin in various pharmaceutical preparations by use of near infrared reflectance spectroscopy.
New methods for the determination of the nominal content of miokamycin in three commercial pharmaceutical preparations available in many different forms are proposed. Solid samples, grinding of which is the sole pretreatment required, are analysed by near infrared (NIR) spectroscopy, using a fibre-optic probe. The active principle is quantified by partial least-squares regression (PLSR). The three proposed methods were validated with a view to their use as control methods; the selectivity of the method, and the repeatability, intermediate precision, accuracy, linearity and robustness of each PLSR calibration model used were determined. The relative standard error of prediction (RSEP) was < 1.5% and the validation results testify to the suitability of the proposed methods.